Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders
Akinori Nishi, Takahide Shuto
Expert Opinion on Therapeutic Targets (2017) Vol. 21, Iss. 3, pp. 259-272
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Role of Dopamine in the Heart in Health and Disease
Joachim Neumann, Britt Hofmann, Stefan Dhein, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 5042-5042
Open Access | Times Cited: 32
Global fungal-host interactome mapping identifies host targets of candidalysin
Tianyi Zhang, Yaoqi Chen, Jing-Cong Tan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Drug addiction: a curable mental disorder?
Jianfeng Liu, Jun‐Xu Li
Acta Pharmacologica Sinica (2018) Vol. 39, Iss. 12, pp. 1823-1829
Open Access | Times Cited: 68
Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations
Pim R.A. Heckman, Arjan Blokland, Eva Bollen, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 87, pp. 233-254
Open Access | Times Cited: 65
Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress
Jiahong Zhong, Hui Yu, Chang Huang, et al.
Redox Biology (2018) Vol. 16, pp. 47-58
Open Access | Times Cited: 64
The Cerebellar Dopaminergic System
Paolo Flace, Paolo Livrea, Gianpaolo Antonio Basile, et al.
Frontiers in Systems Neuroscience (2021) Vol. 15
Open Access | Times Cited: 44
Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases
Yu Xiang, Swapna Naik, Liyun Zhao, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1404-1445
Closed Access | Times Cited: 7
Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation
Haley Geertsma, Terry R. Suk, Konrad M. Ricke, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 21, pp. 3613-3628
Open Access | Times Cited: 22
Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators
Samantha E. Yohn, Daniel J. Foster, Dan P. Covey, et al.
Molecular Psychiatry (2018) Vol. 25, Iss. 11, pp. 2786-2799
Open Access | Times Cited: 45
Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics
Mónica Ferreira, Monique Beullens, Mathieu Bollen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2018) Vol. 1866, Iss. 1, pp. 16-30
Open Access | Times Cited: 44
The potential roles of dopamine in traumatic brain injury: a preclinical and clinical update.
Yu‐Long Lan, Shao Li, Jiacheng Lou, et al.
PubMed (2019) Vol. 11, Iss. 5, pp. 2616-2631
Closed Access | Times Cited: 42
MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson’s disease
Shivani Ghaisas, Monica R. Langley, Bharathi N. Palanisamy, et al.
NeuroToxicology (2019) Vol. 75, pp. 186-199
Open Access | Times Cited: 37
Phosphodiesterase-4 Inhibition in Parkinson’s Disease: Molecular Insights and Therapeutic Potential
Dhritiman Roy, Shivaramakrishnan Balasubramanian, Praveen Thaggikuppe Krishnamurthy, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2713-2741
Closed Access | Times Cited: 12
p-CREB and p-DARPP-32 orchestrating the modulatory role of cAMP/PKA signaling pathway enhanced by Roflumilast in rotenone-induced Parkinson's disease in rats
Reham M. Essam, Esraa A. Kandil
Chemico-Biological Interactions (2023) Vol. 372, pp. 110366-110366
Closed Access | Times Cited: 11
The Role of ΔFosB in the Pathogenesis of Levodopa-Induced Dyskinesia: Mechanisms and Therapeutic Strategies
Mohammad Yasin Zamanian, Zahra Kamran, Marziye Ranjbar Tavakoli, et al.
Molecular Neurobiology (2025)
Closed Access
Environmental enrichment improves deficits in hippocampal neuroplasticity and cognition in prenatally aripiprazole-exposed mouse offspring
Han Wang, Jitao Li, D Liu, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
The involvement of DARPP-32 in the pathophysiology of schizophrenia
Haitao Wang, Mohd Farhan, Jiangping Xu, et al.
Oncotarget (2017) Vol. 8, Iss. 32, pp. 53791-53803
Open Access | Times Cited: 34
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5945-5945
Open Access | Times Cited: 7
Exploring orphan GPCRs in neurodegenerative diseases
Devrim Öz Arslan, Melis Yavuz, Beki Kan
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Early-Life Adversity Induces Epigenetically Regulated Changes in Hippocampal Dopaminergic Molecular Pathways
Jana C. Köhler, Nicole Gröger, Alexandra Lesse, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 5, pp. 3616-3625
Open Access | Times Cited: 20
Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation
Md. Mominur Rahman, Md. Rezaul Islam, Sadia Afsana Mim, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 10
Integrating Imaging Genomic Data in the Quest for Biomarkers of Schizophrenia Disease
Su-Ping Deng, Wenxing Hu, Vince D. Calhoun, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2017) Vol. 15, Iss. 5, pp. 1480-1491
Open Access | Times Cited: 17
Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5
Foteini Vasilopoulou, Andrea Bagán, Sergio Rodríguez‐Arévalo, et al.
Pharmaceutics (2020) Vol. 12, Iss. 5, pp. 475-475
Open Access | Times Cited: 14
Dissecting the neuronal mechanisms of pinoresinol against methamphetamine addiction based on network and experimental pharmacology
Shuyuan Fan, Yize Qi, Fukang Zhang, et al.
Phytomedicine (2024) Vol. 136, pp. 156322-156322
Closed Access | Times Cited: 1
Phosphodiesterase 4 inhibition affects both the direct and indirect pathway: an electrophysiological study examining the tri-phasic response in the substantia nigra pars reticulata
Pim R.A. Heckman, Judith Schweimer, Trevor Sharp, et al.
Brain Structure and Function (2017) Vol. 223, Iss. 2, pp. 739-748
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top